Bazan, Adrian .

HRN: 27-74-18  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
09/02/2025
09/16/2025
PO
1-2ml
QID 3x/week
Immunocompromised State
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines